Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Small Gtpases
|
June 21, 2011
p21-activated kinases in Erbb2-positive breast cancer: A new therapeutic target?
Luis E Arias-Romero, Jonathan Chernoff
Biology of the Cell
|
January 18, 2008
A tale of two Paks
Luis E Arias-Romero, Jonathan Chernoff
Expert Opinion on Therapeutic Targets
|
August 21, 2013
Targeting Cdc42 in cancer
Luis E Arias-Romero, Jonathan Chernoff
Bioscience Reports
|
November 2, 2021
Recent advances in PTP1B signaling in metabolism and cancer
Olga Villamar-Cruz, Marco A Loza-Mejía, Luis E Arias-Romero, et al.
Cancer Research
|
April 12, 2013
Pak1 kinase links ErbB2 to β-catenin in transformation of breast epithelial cells
Luis E Arias-Romero, Olga Villamar-Cruz, Min Huang, et al.
Plos One
|
June 27, 2009
Interaction with LC8 is required for Pak1 nuclear import and is indispensable for zebrafish development
Christine M Lightcap, Gabor Kari, Luis E Arias-Romero, et al.
Current Biology : CB
|
May 31, 2016
H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization
Sonali J Rawat, Daniela Araiza-Olivera, Luis E Arias-Romero, et al.
Cancer Research
|
May 14, 2009
Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells
Luis E Arias-Romero, Sayanti Saha, Olga Villamar-Cruz, et al.
Cell Motility and the Cytoskeleton
|
February 27, 2007
EhGEF3, a novel Dbl family member, regulates EhRacA activation during chemotaxis and capping in Entamoeba histolytica
Luis E Arias-Romero, Claudia H Gonzalez de la Rosa, Ma de Jesús Almaráz-Barrera, et al.
Oncotarget
|
October 15, 2016
Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition
Olga Villamar Cruz, Tatiana Y Prudnikova, Daniela Araiza-Olivera, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Small Gtpases
|
June 21, 2011
p21-activated kinases in Erbb2-positive breast cancer: A new therapeutic target?
Luis E Arias-Romero, Jonathan Chernoff
Biology of the Cell
|
January 18, 2008
A tale of two Paks
Luis E Arias-Romero, Jonathan Chernoff
Expert Opinion on Therapeutic Targets
|
August 21, 2013
Targeting Cdc42 in cancer
Luis E Arias-Romero, Jonathan Chernoff
Bioscience Reports
|
November 2, 2021
Recent advances in PTP1B signaling in metabolism and cancer
Olga Villamar-Cruz, Marco A Loza-Mejía, Luis E Arias-Romero, et al.
Cancer Research
|
April 12, 2013
Pak1 kinase links ErbB2 to β-catenin in transformation of breast epithelial cells
Luis E Arias-Romero, Olga Villamar-Cruz, Min Huang, et al.
Plos One
|
June 27, 2009
Interaction with LC8 is required for Pak1 nuclear import and is indispensable for zebrafish development
Christine M Lightcap, Gabor Kari, Luis E Arias-Romero, et al.
Current Biology : CB
|
May 31, 2016
H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization
Sonali J Rawat, Daniela Araiza-Olivera, Luis E Arias-Romero, et al.
Cancer Research
|
May 14, 2009
Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells
Luis E Arias-Romero, Sayanti Saha, Olga Villamar-Cruz, et al.
Cell Motility and the Cytoskeleton
|
February 27, 2007
EhGEF3, a novel Dbl family member, regulates EhRacA activation during chemotaxis and capping in Entamoeba histolytica
Luis E Arias-Romero, Claudia H Gonzalez de la Rosa, Ma de Jesús Almaráz-Barrera, et al.
Oncotarget
|
October 15, 2016
Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition
Olga Villamar Cruz, Tatiana Y Prudnikova, Daniela Araiza-Olivera, et al.
Page
of 2